Sparc Share Price (SPARC)
as on
| Source : NSE
Sparc Stock Performance
as on August 26, 2025 at 4:01 pm IST
Day's Low
Day's High
₹142.1₹145.18
0.34%
Downside
1.82%
Upside
52 Week's Low
52 Week's High
₹109.3₹24123.35%
Downside
69.02%
Upside
| Market Stats | |
| Previous Close | ₹144.72 |
| Open | ₹144.30 |
| Volume | 1.96L |
| Upper Circuit | ₹173.66 |
| Lower Circuit | ₹115.77 |
| Day's Low | ₹142.1 |
| Day's High | ₹145.18 |
| 52 Week Low | ₹109.3 |
| 52 Week High | ₹241 |
| Returns % | |
| 1 Month Return | -4.92 % |
| 3 Month Return | -11.6 % |
| 1 Year Return | -38.78 % |
| 3 Year Return | -37.84 % |
| 5 Year Return | -21.8 % |
Sparc Stock Fundamentals & Key Indicators
Check Sparc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹4,627.35 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
-15.5
Return on capital employed (ROCE)
0Industry PE ratio
43.96
Beta (LTM)
1.37
P/B Ratio
-21.76
Dividend Yield
0PEG Ratio
-5.64
Quarterly Earnings Growth YOY
-45.91
EPS (TTM)
-10.55
Sector
Pharmaceuticals
Book Value
-6.68
Technical Analysis
Bearish
View Technical Analysis
Sparc Stock's Interest Amongst Investors
Sparc Stock Valuation
Track how Sparc P/E has moved over time to understand its valuation trends.
Sparc in the last 5 years
Lowest (-38.16x)
April 8, 2024
Today (-15.50x)
August 26, 2025
Industry (43.96x)
August 26, 2025
Highest (0.00x)
December 29, 2023
Today’s Price to Earnings Ratio: -15.50x
Sun Pharma Advanced Research Company Ltd Financial Results
Get the annual and quarterly financial summary of Sun Pharma Advanced Research Company Ltd, including revenue, profit, loss and more.
Sparc Earnings and Dividends
View detailed summary of the earnings and dividend history of Sparc.
Sun Pharma Advanced Research Company Ltd Earnings Results
Sun Pharma Advanced Research Company Ltd’s net profit jumped 45.91% since last year same period to ₹-51.87Cr in the Q1 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 13.22% jump in its net profits since last 3-months.
Read More about Earnings Results
Indices Featuring Sparc Stock
Check stock indices that include Sparc.
Sparc Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Sparc.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 65.67% | 0.00 | |
| Foreign Institutions | 1.47% | 1.81 | |
| Mutual Funds | 0.94% | ||
| Retail Investors | 31.88% | 0.42 | |
| Others | 0.03% |
Sun Pharma Advanced Research Company Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Sparc with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 4,627.35 | -4.36% | 1.88 | -343 | 71 | |
| BUY | 33,698.43 | 31.22% | 0.52 | 300 | 1,051 | |
| BUY | 16,603.84 | 8.81% | 0.71 | 836 | 7,234 | |
| BUY | 15,313.09 | 46.98% | 0.67 | 244 | 1,515 | |
| HOLD | 21,056.50 | 76.5% | 0.56 | 258 | 1,375 |
Sparc News & Key Events
Latest news and events in one place to help you make informed investing decisions in Sparc.
SPARC Maintains Stability Despite Trial Discontinuation - 05 Jun, 2025
Sun Pharma Advanced Research Co. reassured investors that the discontinuation of SCD-044 trials will not impact financials. The company highlighted multiple promising assets in its pipeline, including SBO-154 and SCD-153, which are set to advance in clinical trials. SPARC anticipates stable cash flow from licensing these assets, offsetting any losses from discontinued projects.SPARC Stock Plummets After Drug Trial Failures - 04 Jun, 2025
Sun Pharma Advanced Research Company (SPARC) shares fell nearly 20% after Vibozilimod failed Phase 2 trials for psoriasis and atopic dermatitis, prompting a reevaluation of their pipeline and strategies.
Insights on Sun Pharma Advanced Research Company Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 31.75% to 31.88% in Jun 2025 quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.45% to 1.47% in Jun 2025 quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 133.9% return, outperforming this stock by 171.7%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 26.3% return, outperforming this stock by 65.1%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 65.67% of holdings in Jun 2025 quarter
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 1.01% to 0.94% in Jun 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 1 year, SPARC stock has moved down by -38.8%
About Sun Pharma Advanced Research Company Ltd
Revenue: ₹9.64Cr as on June 2025 (Q1 FY26)
Net Profit: ₹-51.87Cr as on June 2025 (Q1 FY26)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
| Organisation | Sun Pharma Advanced Research Company Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Dilip S Shanghvi |
| E-voting on shares | Click here to vote |
Mutual Funds that own Sparc Stock
Check out the Mutual Funds with significant holdings in Sparc.
FAQs
What is Sparc share price today?
Sparc share price today stands at ₹142.59, Open: ₹144.3, Previous Close: ₹144.72, High: ₹145.18, Low: ₹142.1, 52 Week High: ₹241, 52 Week Low: ₹109.3 as on .
How to buy Sparc shares ?
To buy Sparc shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for SPARC or Sun Pharma Advanced Research Company Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Sparc shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Sparc?
Today's traded volume of Sparc is 1.96L. Which means that 1.96L shares of Sparc were bought and sold on the stock market during today's trading session.
What is Sparc's market cap today?
Today's market capitalisation of Sparc is ₹4,627.35 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Sparc?
Sparc’s 52 week high is ₹241 and 52 week low is ₹109.3. The current share price of Sparc is ₹142.59, which is -40.83% down from its 52 week high and 30.46% up from its 52 week low.